ARCHIVES

NCI To Recompete Drug Discovery Groups In 2003 As Program Nears Its 20th Year

This article is from The Cancer Letter archive.

Vol. 28 No. 44 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

Decision On New Division Two-Three Weeks Away: Upton

August 17, 1979

Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer

November 28, 2014

FDA Grants Accelerated Approval To Ferriprox for Iron Overload

October 28, 2011

In Brief: Moffitt Center Makes Major Recruitment Effort; Komen Foundation Invites Award Nominations

May 28, 1993

Exercisers May Have Higher Breast Cancer Survival

October 27, 2006

NTP Release Third Report On Carcinogens

January 13, 1984